Pennsylvania-based Complexa Inc, a clinical stage biopharmaceutical company, has closed $62 million in Series C funding. New Enterprise Associates and Pfizer Venture Investments LLC led the round with participation from other investors that included Edmond de Rothschild Investment Partners and HBM Healthcare Investments.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: